The Global Antibiotic Research and Development Partnership (GARDP) is a Swiss nonprofit pharmaceutical research and development organization that aims to assist antibiotic drug development to counter the threat of antibiotic resistance. It was founded in 2016 by the World Health Organization and the Drugs for Neglected Diseases initiative. GARDP became a Swiss foundation in 2018.
References
- Årdal, Christine; Balasegaram, Manica; Laxminarayan, Ramanan; McAdams, David; Outterson, Kevin; Rex, John H.; Sumpradit, Nithima (May 2020). "Antibiotic development — economic, regulatory and societal challenges". Nature Reviews Microbiology. 18 (5): 267–274. doi:10.1038/s41579-019-0293-3. ISSN 1740-1534. PMID 31745330.
- "The Global Antibiotic Research and Development Partnership (GARDP)". www.who.int. Retrieved 2024-12-25.
- "Globale Antibiotika Forschungs- und Entwicklungs-Partnerschaft (Global Antibiotic Research and Development Partnership - GARDP) - DLR Gesundheitsforschung". Deutsche Zentrum für Luft und Raumfahrt e.V. - DLR Gesundheitsforschung (in German). Retrieved 2024-12-25.
- ^ "Lobbyregistereintrag "GARDP Foundation (Global Antibiotic Research and Development Partnership)"". Lobbyregister beim Deutschen Bundestag (in German). Retrieved 2024-12-25.
- Wasan, Himika; Singh, Devendra; Reeta, K. H.; Gupta, Yogendra Kumar (2023-01-09). "Landscape of Push Funding in Antibiotic Research: Current Status and Way Forward". Biology. 12 (1): 101. doi:10.3390/biology12010101. PMC 9855914. PMID 36671792.
See also
External links
 | This organization-related article is a stub. You can help Misplaced Pages by expanding it. |
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |
 | This medical article is a stub. You can help Misplaced Pages by expanding it. |